Skip Navigation
 

Southeastern Kidney Disease Consortium

Southeastern Kidney Disease Consortium - 2nd Annual Meeting 2013

Click here.

Welcome to the 2nd Annual SEKDC Conference!

Nephrologists, other physicians, nurses, physicians assistants and researchers interested in novel research discoveries, and evidence-based best practices, treatment and management of patients with Kidney Disease, Acute Kidney Injury, FSGS, Lupus Nephritis and comorbid conditions are invited to attend the SEKDC 2nd Annual Meeting in Charleston, South Carolina on September 6 - 7, 2013 to be held at the The Francis Marion Hotel in Charleston, South Carolina.        
                      
 

Conference Schedule

(The Medical University of South Carolina designates this live activity for a maximum of 8.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.)

Friday, September 6, 2013

6:00 PMRegistration and Cocktails
6:30 PMWelcome
6:45 PMDinner
7:15 PM   
 

Barry Freedman, MD  Wake Forest University, Winston-Salem, North Carolina

"Genetic susceptibility to kidney disease in diabetes."
  Objectives:
  • Describe the genetic basis of susceptibility to kidney disease and identify opportunities for future studies in diabetic nephropathy.
  • Collaborate and engage in continued research using combined analysis of well- characterized data sets for better generalization of results.
  • Explain the current state of genetics research linking kidney disease and diabetes and discuss recommendations for future genetic studies in DNA.

Saturday , September 7, 2013

7:00 AM
Registration and Full Breakfast
7:45 AM
Welcome and Introduction
Session 1: Acute Kidney Injury
  Moderators
John Arthur, MD, PhDJohn Arthur, MD, PhD  Medical University of South Carolina
8:00 AM
"Right Fluid, Right Patient, Right Time"   
  Objective: Administer the appropriate type of fluid use in the management of critically ill patients.
8:30 AM
"Novel Potential Therapies for AKI"
  Objective: Discuss new potential treatments for AKI.
9:00 AM
 
"Process of Care Experienced by Patients who Survive an Episode of AKI"
  Objective: Recognize long-term consequences of AKI and apply the appropriate follow-up according to the KDIGO Guidelines."
9:30 AM
Discussion
10:00 AM
Break
Session 2: Management of CKD
  Moderators
10:15 AM
 "RAS Blockade in CKD: Enough is Enough?" 
  Objective: Determine the advantages and disadvantages to treatment with more than one RAS pathway inhibitor.
10:45 AM
  Objective: Select the appropriate dosing of ESAs in CKD.
11:15 AM
 
"Metabolic Syndrome and Progression of CKD" 
  Objective: Manage the interactions of metabolic syndrome and CKD.
11:45 AM
Discussion
 
12:15 PM
Lunch
Session 3: Glomerular Disease
 Moderators
1:00 PM
 
"Novel Treatment Methodologies in FSGS"
  Objective: Discuss new evidenced-based treatment approaches for patients with FSGS.
1:30 PM
"Current Clinical Research in Anti-neutrophil Cytoplasmic Antibody Glomerulonephritis"
  Objective: Identify best practices for diagnosing ANCA positive vasculitis and adopt methods to detect this condition early and prevent renal deterioration.
2:00 PM
"Using Discriminant Analysis to Develop Composite Biomarkers of Kidney Pathology in Lupus Nephritis"
  Objective: Consider new treatment modalities for lupus nephritis.
2:30 PM
Discussion
3:00 PM
Break
Session 4: Management of End Stage Renal Disease
 Moderators
Titte Srinvas
3:15 PM
"Vascular Access: What General Nephrologists Need to Know"
  Objective: Describe appropriate indications and techniques for maintaining vascular access patency.
3:45 PM
Titte Srinvas
"Update in Renal Transplantation"
  Objective: Discuss new treatment options for patients with renal transplantation.
4:15 PM
"Telehealth Interventions to Slow Progression of Kidney Disease: Reducing the Human and Economic Costs"
  Objective: Explain how novel interventions in telemedcine may ne used to slow progression of kidney disease.
4:45 PM
Discussion
5:15 PM
Closing Remarks
 Conference Details
About the Conference
Host Hotel
Conference Room Rates: $169.00 per night
Room Block is FULL as of 08/28/2013.
387 King Street  
Charleston, SC 29403
For Reservations Call: 843-722-0600
Toll Free Reservations: 877-756-2121   
 
Over Flow

5 Rooms are available at the Fulton Lane Inn for $179.00 per night.

Please call to make your reservation and reference the SEKDC Conference.

The Fulton Lane Inn

202 King Street  |  Charleston, SC 29401  |  (843) 720-2600  |  (800) 720-2688

http://www.fultonlaneinn.com

Registration
Conference Attendees
Friday Dinner Only:
$145.00
Saturday Conference Only:
$195.00
Friday Dinner and Saturday Conference:
$235.00
Students, Residents and Fellows
Friday Dinner Only:
$73.00
Saturday Conference Only:
$98.00
Friday Dinner and Saturday Conference:
$118.00
How to Register
Online
Visit http://www.musc.edu/nephrology/conferences/SEKDC/index.htm. Complete the online registration form and then submit. You will receive a confirmation email following a successful transaction.
Mail
Mail the registration form with check or credit card information to:
Elizabeth Shewfelt
MUSC - Division of Nephrology
Strom Thurmond Building
114 Doughty Street, BM 401
Charleston, SC, 29425
By Phone or Fax:
  Telephone:  (843) 792-6109– Registration by credit card only     
  Fax: (843) 876-5129 – Registration by credit card only 
Cancellations
A refund will be made upon written request prior to August 7, 2013; however, $100 will be retained for administrative costs. No refunds will be made after August 7, 2013. We reserve the right to cancel the program if necessary. Full registration fees will be refunded for canceled programs. The Medical University of South Carolina cannot be responsible for reimbursement of airline or other transportation fares, hotel or rental car charges, including penalties.
The Medical University of South Carolina's Division of Nephrology proudly presents the 2013 Southeastern Kidney Disease Consortium (SEKDC) 2nd Annual Meeting.
Statement of Need
The educational content of this activity is relevant to adult and pediatric nephrologists, transplant surgeons and primary care practitioners including internal medicine, pediatric and family physicians. The conference will provide participants with tools to correctly identify and determine optimal prevention and treatment of patients with acute and chronic kidney disease and ESRD. The conference will provide strategies to deal with complex renal problems such as optimal fluid management of ICU patients, the effect of acute kidney injury on progression of chronic kidney disease, management of glomerulonephritis and new approaches to dealing with dialysis vascular access. The strategies outlined will lead to improved patient outcomes. By incorporating interactive techniques, such as audience response system and case based discussion, attendees will be able to closely engage with the faculty for a more effective delivery of guidelines for problem solving strategies that can be directly implemented in their practices. Many advances in the diagnosis and treatment of kidney diseases have been made recently. This conference will provide updates in areas that are highly relevant to the daily practice of physicians who treat patients with kidney disease.
Course Description
This course is designed for nephrologists and other physicians interested in the treatment of patients with Kidney Disease. The meeting will consist of educational sessions in the areas of acute kidney injury, nephrotic syndrome, chronic kidney disease and end stage renal disease as well as planning sessions to discuss collaborations in research and clinical issues.
CME Information
Accreditation
This activity has been planned and implemented in accordance with Essential and Standards of Accreditation Council for Continuing Medical Education through sponsorship of the Medical University of South Carolina. The Medical University of South Carolina is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
The Medical University of South Carolina designates this live activity for a maximum of  8.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure
In accordance with the ACCME Essentials Standards, anyone involved in planning or presenting at this educational activity will be required to disclose any relevant financial relationships with commercial interests in the healthcare industry. This information will be made available to participants at the beginning of the activity. Speakers who incorporate information about off-label or investigational use of drugs or devices will be asked to disclose that information at the beginning of their presentation.
Americans with Disabilities Act
It is the policy of the Medical University of South Carolina not to discriminate against any person on the basis of disabilities. If you feel you need services or the auxiliary aids mentioned in this act in order to fully participate in this continuing medical education activity please call Elizabeth Shewfelt at 843-792-6109 or via email shewfelt@musc.edu, or attach a note to your registration.
Acknowledgements
We would like to acknowledge the following companies for their support of this activity through educational grants:
 
We would like to acknowledge the following companies for their support of this activity through exhibits:
 
 
 
 

© 2012  Medical University of South Carolina | Disclaimer